Sepp has extensive experience in the development and implementation of novel diagnostic and prognostic methods using machine learning within the fields of radiology and pathology. He was central in the development of DoMore Diagnostics’ technology as Senior Developer at the Institute of Cancer Genetics and Informatics at Oslo University Hospital. The work resulted in the first fully automated method predicting prognosis for cancer patients from histopathology images, published in The Lancet. Sepp earned his MSc at Delft University of Technology (NL) and his PhD at Aarhus University (DK).

• 

  Chief Technology Officer (CTO) & Co-founder in DoMore

  Personalized medicine made simple with artificial intelligence